This episode features Dr. Aleppo, an endocrinologist, who has a commercial relationship with Insulet and was compensated for her participation in the podcast.  Dr. Grazia Aleppo returns to Beyond the Bolus to share her insights from ADA 2025 and beyond. In this engaging conversation, Dr. Aleppo discusses the evolution of automated insulin delivery (AID) systems, the RADIANT and SECURE-T2D clinical trials, and why Omnipod® 5 is changing the game for people with both type 1 and type 2 diabetes. From helping patients to overcome fears of hypoglycemia to simplifying care, Dr. Aleppo emphasizes the importance of challenging outdated assumptions about who benefits from AID and underscores the need for simple, more adaptable solutions for every patient.